Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05077722
Other study ID # 21-007403
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 24, 2022
Est. completion date December 1, 2023

Study information

Verified date March 2024
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to develop an innovative wearable tracking protocol that will use Artificial Intelligence (AI) technology to monitor sleep and behavior of 3-7 year old children.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date December 1, 2023
Est. primary completion date December 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 3 Years to 99 Years
Eligibility Inclusion Criteria - Children: - Ages 3-7. - Outpatients or Inpatients. - Any gender, race or ethnicity. - Able to provide developmentally appropriate informed assent, and legal guardians able to provide informed consent . - EBP Severity rated above the clinically significant range (=120; T-score = 60) (Eyberg Child Behavior Inventory- ECBI; Eyberg & Pincus, 1999). - Need for more intensive behavioral treatments such as ER visit for behavioral dyscontrol or hospitalization will not be exclusionary or exit criteria. - Families approached for participation will be asked to commit to complete the treatment. - At least one primary caregiver and the identified child will have to be able to speak and understand English. Exclusion Criteria - Children: - Formal diagnosis of Severe Intellectual disability, Autistic Spectrum Disorder Level 3, or a psychotic disorder for the child. - Parents not consenting to the study. - Parents or child is not able to adhere to the study protocol. - A Child who is reasonable expected to be unable to tolerate wearing the Garmin device for at least 70% of the time during the day and night 70% of the days during the treatment (12 weeks). This is based on the principal investigator's discretion. - Unable to speak and understand English. - Refusal or withdrawal of consent, inability, or unwillingness to adhere to study procedures. - Children in foster care. Inclusion Criteria - Adults: - Agree to wear Garmin watch. - Ages 18-99. - Any gender, race, ethnicity. - Able to provide informed consent. Exclusion Criteria - Adults: - Unable to speak and understand English. - Refusal or withdrawal of consent, inability, or unwillingness to adhere to study procedures.

Study Design


Intervention

Device:
Garmin
A smartwatch device that measures subjects level of activity, heartrate, respirations and quality of your sleep at night. Artificial intelligence will be applied to analyze all the data over the course of 12 weeks to monitor and attempt to predict the onset of tantrums or disruptive behavior. Subjects are required to wear the watch at least 70% of the day and night each day for 70% of days during 12 weeks of treatment.

Locations

Country Name City State
United States Mayo Clinic in Rochester Rochester Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Frequency of Garmin use Number of days participants wear the Garmin smartwatch 12 weeks
Secondary Eyberg Child Behavior Inventory The Eyberg Child Behavior Inventory questionnaire is measured on two subscales for a series of phrases that describe a children's behavior. The first subscale is for indicating the frequency of the behavior using a scale of 1= never to 7 = Always; the second subscale indicates yes = 1 or no = 0 for whether the behavior is currently a problem for them. Reponses are total with a higher score indicating greater severity of child's behavior. 12 weeks
Secondary Pediatric Sleep Questionnaire Pediatric Sleep Questionnaire to assess child's sleep with a series of 22 questions on a yes/no problem scale. 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT03535805 - Transdiagnostic, Cognitive and Behavioral Intervention for in School-aged Children With Emotional and Behavioral Disturbances N/A
Completed NCT02485587 - Arousal-Biofeedback for the Treatment of Aggressive Behavior in Children and Adolescents N/A
Completed NCT00819429 - Supplements and Social Skills Intervention Study N/A
Completed NCT01085305 - The Effectiveness of Parent-Child Interaction Therapy (PCIT) N/A
Completed NCT00250354 - A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation Phase 3
Completed NCT05496140 - Remote School-Home Program to Improve Youth Attention and Behavior in Mexican Students N/A
Completed NCT05425966 - Adapting a Web-Based Professional Development for Mexican School Mental Health Providers Delivering Evidence-Based Intervention for ADHD and ODD N/A
Active, not recruiting NCT05049356 - Symptoms and Mechanisms of Child Psychiatric Disorders
Completed NCT03698240 - Mindfulness-based Program for Children With Disruptive Behavior Disorder N/A
Completed NCT02766101 - Manville Moves: an Exercise Intervention for Behavioral Regulation Among Children With Behavioral Health Challenges N/A
Completed NCT00404911 - Multi-Family Group Therapy for Reducing Behavioral Difficulties in Youth N/A
Completed NCT00192023 - An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD). Phase 3
Completed NCT03292848 - Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders Phase 1
Recruiting NCT05637320 - Big Feelings: A Study on Children's Emotions in Therapy N/A
Recruiting NCT06373484 - Matching Assessment and Treatment for Children With Disruptive Behaviour and Their Parents N/A
Completed NCT03729154 - Preschool First Step to Success: An Efficacy Replication Study N/A
Completed NCT02281825 - Correlating Real and Virtual World Behavioral Fluctuations in Adolescence N/A
Completed NCT01822392 - On-line Treatment for Conduct Problems N/A
Completed NCT00406354 - Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany Phase 4
Completed NCT02783560 - Behavioral Sleep Intervention in Children With Disruptive Behaviors N/A